关键词：丙型肝炎；病毒感染；肝脏
摘 要：Hepatitis C is a viral infection caused by the hepatitis C virus. It predominantly affects the liver; however, other parts of the body such as the brain and digestive system can also be affected.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Disease Overview

06.1 Mode of Infection Transmission

06.2 Geographical Distribution

06.3 Screening

06.4 Treatment

06.4.1 WHO Guidelines

06.4.2 AASLD Guidelines

07. Market Landscape

07.1 Market Overview

07.2 Market Size and Forecast

07.3 Five Forces Analysis

08. Key Marketed Drugs for Treatment of

Chronic Hepatitis C

09. Market Segmentation by MOA

09.1 Virus-specific Agents

09.1.1 Polymerase Inhibitors

09.1.2 Protease Inhibitors

09.2 Non-specific Agents

09.2.1 IFN-based Drugs

09.2.2 Other Drugs

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

18.1 Competitive Scenario

18.1.1 Key News

18.1.2 Mergers and Acquisitions

18.2 Market Share Analysis 2013

18.2.1 F. Hoffmann-La Roche

18.2.2 Merck

18.2.3 Johnson & Johnson

18.2.4 Vertex Pharmaceuticals

18.2.5 Gilead Sciences

18.3 Other Prominent Vendors

19. Key Vendor Analysis

19.1 F. Hoffmann-La Roche

19.1.1 Key Facts

19.1.2 Business Overview

19.1.3 Business Segmentation

19.1.4 Business Segmentation by Revenue 2012 and 2013

19.1.5 Geographical Segmentation by Revenue 2013

19.1.6 Business Strategy

19.1.7 Recent Developments

19.1.8 SWOT Analysis

19.2 Gilead Sciences

19.2.1 Key Facts

19.2.2 Business Overview

19.2.3 Geographical Segmentation by Revenue 2013

19.2.4 Recent Developments

19.2.5 SWOT Analysis

19.3 Johnson & Johnson

19.3.1 Key Facts

19.3.2 Business Overview

19.3.3 Business Segmentation by Revenue 2013

19.3.4 Business Segmentation by Revenue 2012 and 2013

19.3.5 Geographical Segmentation by Revenue 2013

19.3.6 Business Strategy

19.3.7 Recent Developments

19.3.8 SWOT Analysis

19.4 Merck

19.4.1 Key Facts

19.4.2 Business Overview

19.4.3 Business Segmentation by Revenue 2013

19.4.4 Business Segmentation by Revenue 2012 and 2013

19.4.5 Geographical Segmentation by Revenue 2013

19.4.6 Business Strategy

19.4.7 Key Developments

19.4.8 SWOT Analysis

19.5 Vertex Pharmaceuticals

19.5.1 Key Facts

19.5.2 Business Overview

19.5.3 Business Segmentation by Revenue 2013

19.5.4 Business Segmentation by Revenue 2012 and 2013

19.5.5 Geographical Segmentation by Revenue 2013

19.5.6 Business Strategy

19.5.7 Recent Developments

19.5.8 SWOT Analysis

20. Other Reports in this Series